Kevin Connolly Featured in the Latest Issue of PharmaVOICE on Precision Medicine

November 22, 2016

PharmaVOICE, Nov./Dec. 2016 issue – Precision medicine holds great promise for improving patient health outcomes. By identifying genetic causes of diseases, doctors can focus on disease prevention, earlier diagnosis when treatments may be more effective, and avoid giving treatments to patients that may cause adverse reactions or that will fail to work.

C3iHC’s vice president of account management, Kevin Connolly, shares his vision on the influence of precision medicine over patient support and adherence programs. Find more about the trends for 2017 when it comes to precision medicine in latest issue of PharmaVoice.

Read the full article – Trending 2017: Precision Medicine

The Experience Matters.

As an industry leader in business process outsourcing, HCL Technologies delivers global, multi-channel engagement solutions. The Experience Matters. Let us show you why.

Contact Us